AwesomeCapital
Friday, May 31, 2019
Genocea gains ahead of GEN-009 data at ASCO
›
Thinly traded nano cap Genocea Biosciences (NASDAQ: GNCA ) is up 3% premarket on increased volume (~30K shares) on the heels of its anno...
Kite, Humanigen Collaborate on Yescarta Combo for Large B-Cell Lymphoma
›
Kite, a Gilead Company (Nasdaq: GILD), and Humanigen, Inc. (HGEN) announced today the formation of a clinical collaboration to conduct a ...
Turning Point Therapeutics Updates Lung Cancer Data
›
In TKI-naïve ROS1+ Patients, Overall Response Rate by Blinded Review is 82 Percent, and 83 Percent at Likely Recommended Phase 2 Dose of 16...
Merck has final data from late-stage study of Keytruda in head-neck cancer
›
Merck (NYSE: MRK ) announces the final analysis of the Phase 3 KEYNOTE-048 clinical trial evaluating KEYTRUDA (pembrolizumab), combined...
Iovance up on updated data
›
Iovance Biotherapeutics (NASDAQ: IOVA ) is up 2% premarket on light volume on the heels of updated data on tumor-infiltrating lymphocyt...
Twist Bioscience started at Outperform by Evercore ISI
›
https://www.benzinga.com/stock/TWST/ratings
Minerva Neurosciences started at Buy by Wainwright
›
T arget $22. https://www.benzinga.com/stock/NERV/ratings
‹
›
Home
View web version